U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07197957) titled 'Cystatin and Early AKI Detection Contrast Induced Acute Kidney Injury' on Sept. 25.
Brief Summary: To determine the clinical utility of serum cystatin C in early detection of acute kidney injury (AKI).
Study Start Date: March 11
Study Type: OBSERVATIONAL
Condition:
Acute Kidney Injury
Recruitment Status: RECRUITING
Sponsor: BayCare Health System
Disclaimer: Curated by HT Syndication....